Cargando…
Randomised Double-Blind Comparison of Placebo and Active Drugs for Effects on Risks Associated with Blood Pressure Variability in the Systolic Hypertension in Europe Trial
BACKGROUND: In the Systolic Hypertension in Europe trial (NCT02088450), we investigated whether systolic blood pressure variability determines prognosis over and beyond level. METHODS: Using a computerised random function and a double-blind design, we randomly allocated 4695 patients (≥60 years) wit...
Autores principales: | Hara, Azusa, Thijs, Lutgarde, Asayama, Kei, Jacobs, Lotte, Wang, Ji-Guang, Staessen, Jan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121168/ https://www.ncbi.nlm.nih.gov/pubmed/25090617 http://dx.doi.org/10.1371/journal.pone.0103169 |
Ejemplares similares
-
Risk factors for predicting heart failure: a subject-level meta-analysis from the HOMAGE database
por: Efremov, Ljupcho, et al.
Publicado: (2015) -
Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension
por: Huang, Qi-Fang, et al.
Publicado: (2021) -
How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)
por: Thijs, Lutgarde, et al.
Publicado: (2001) -
Public and occupational health risks related to lead exposure updated according to present-day blood lead levels
por: Yu, Yu-Ling, et al.
Publicado: (2022) -
Risk Stratification by Self-Measured Home Blood Pressure across Categories of Conventional Blood Pressure: A Participant-Level Meta-Analysis
por: Asayama, Kei, et al.
Publicado: (2014)